ProfileGDS4459 / ENSG00000142751
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 65% 39% 67% 48% 64% 44% 64% 64% 59% 71% 41% 66% 69% 66% 69% 68% 33% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.9865
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.0739
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.2267
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.4248
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.9764
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.1944
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.0764
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.0264
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.7959
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.4671
GSM623474group B, liver allograft wedge biopsie placebo treatment 1441
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.1866
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.369
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.9966
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.3869
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.0968
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.8533